BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 34 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9,318 | -41.8% | 12,941 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $16,000 | +6.7% | 12,941 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $15,000 | -46.4% | 12,941 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $28,000 | +47.4% | 12,941 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $19,000 | -50.0% | 12,941 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $38,000 | -11.6% | 12,941 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $43,000 | -12.2% | 12,941 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $49,000 | +6.5% | 12,941 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $46,000 | -45.9% | 12,941 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $85,000 | -11.5% | 12,941 | 0.0% | 0.01% | -11.1% |
| Q2 2020 | $96,000 | +57.4% | 12,941 | 0.0% | 0.01% | +28.6% |
| Q1 2020 | $61,000 | – | 12,941 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 448,101 | $537,000 | 0.11% |
| Long Focus Capital Management, LLC | 327,692 | $393,000 | 0.04% |
| Boxer Capital, LLC | 56,950 | $68,000 | 0.00% |
| SHUFRO ROSE & CO LLC | 12,941 | $16,000 | 0.00% |
| Baker Brothers Advisors | 249,123 | $299,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 45,057 | $54,000 | 0.00% |
| Orion Capital Management LLC | 500 | $1,000 | 0.00% |
| Parallel Advisors, LLC | 10 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 779 | $1,000 | 0.00% |
| NORTHERN TRUST CORP | 10,981 | $13,000 | 0.00% |